Novel VCP mutations expand the mutational spectrum of frontotemporal dementia

Neurobiol Aging. 2018 Dec:72:187.e11-187.e14. doi: 10.1016/j.neurobiolaging.2018.06.037. Epub 2018 Jun 30.

Abstract

Valosin-containing protein (VCP) mutations are rare causes of autosomal dominant frontotemporal dementias associated with Paget's disease of bone, inclusion body myopathy, and amyotrophic lateral sclerosis. We analyzed the VCP gene in a cohort of 199 patients with frontotemporal dementia and identified 7 heterozygous mutations in unrelated families, including 3 novel mutations segregating with dementia. This expands the VCP mutation spectrum and suggests that although VCP mutations are rare (3.5% in this study), the gene should be analyzed even in absence of the full syndromic complex. Reporting genetic variants with convincing arguments for pathogenicity is important considering the large amount of data generated by next-generation sequencing and the growing difficulties to interpret rare genetic variants identified in isolated cases.

Keywords: Amyotrophic lateral sclerosis; Frontotemporal dementia; Frontotemporal lobar degeneration; Paget's disease of bone; TAR DNA binding protein 43; Valosin containing protein.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • Frontotemporal Dementia / genetics*
  • Frontotemporal Dementia / physiopathology*
  • Humans
  • Male
  • Middle Aged
  • Mutation, Missense
  • Pedigree
  • Valosin Containing Protein / genetics*

Substances

  • VCP protein, human
  • Valosin Containing Protein